As a member of the Parabilis Medicines team, you will be a part of an organization dedicated to creating extraordinary medicines for diseases with urgent unmet needs, harnessing our proprietary peptide platform to transform treatment possibilities for patients. Parabilis is a clinical-stage biopharmaceutical company dedicated to unlocking high-impact protein targets long-considered undruggable. The company has developed a new class of stabilized, cell-penetrant alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that are inaccessible to traditional drug modalities. Headquartered in Cambridge, Mass., Parabilis is advancing a focused pipeline of multiple first-in-class therapies across both rare and common cancers. Its lead asset, zolucatetide (FOG-001), is a first-in-class, clinically validated direct inhibitor of the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors, implicated in millions of cancer cases annually, including in colorectal cancer, desmoid tumors, hepatocellular carcinoma and a range of other Wnt/β-catenin-driven tumors. In Phase 1 clinical trials, zolucatetide produced the first-ever clinical evidence that it can directly inhibit this interaction, once previously considered “undruggable” despite its role across multiple cancer types. Parabilis is also advancing investigational degraders of ERG and ARON into clinical development for the treatment of prostate cancer, as well as progressing other preclinical programs. Backed by a recent $305 million Series F financing, Parabilis is entering an exciting phase of growth and execution. What’s the opportunity? Parabilis Medicines has built an in-house, high-throughput multiplexed screening platform that links Helicon discovery to rapid, decision-quality testing against challenging targets. As our pipeline expands, we are scaling capacity and improving assay robustness by standardizing workflows so multiple programs can run in parallel with reproducible, high-quality outputs. We are seeking a Scientist with a chemical biology mindset and strong quantitative experimental rigor to help advance and scale this platform. In this role, you will co-own execution of multiplexed screening assays and lead efforts to improve throughput, robustness, and data quality through assay optimization, automation, and workflow standardization. Over time, you will deepen your understanding of Helicon design and use high-quality assay data to contribute to property optimization and SAR learning.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree